Stay updated on rAAV2tYF-GRK1-RPGR in RPGR XLRP Clinical Trial
Sign up to get notified when there's something new on the rAAV2tYF-GRK1-RPGR in RPGR XLRP Clinical Trial page.

Latest updates to the rAAV2tYF-GRK1-RPGR in RPGR XLRP Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision: v3.5.0 is now displayed; the previous Revision: v3.4.3 has been removed.SummaryDifference0.1%

- Check39 days agoChange DetectedPage revision updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page shows a minor revision metadata update from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision: v3.3.4 appears with no substantive changes to study details or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check112 days agoChange DetectedIntroduced a Locations section listing North Carolina, Ohio, Oregon, and Texas, and removed the previous state-location subsections and the HHS Vulnerability Disclosure entry. The revision tag was updated to v3.3.3.SummaryDifference0.6%

Stay in the know with updates to rAAV2tYF-GRK1-RPGR in RPGR XLRP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the rAAV2tYF-GRK1-RPGR in RPGR XLRP Clinical Trial page.